Literature DB >> 10460892

Distribution of osteopontin and calprotectin as matrix protein in calcium-containing stone.

T Tawada1, K Fujita, T Sakakura, T Shibutani, T Nagata, M Iguchi, K Kohri.   

Abstract

We recently reported that osteopontin (OPN) and calprotectin (CPT) are present in the matrix of urinary calcium stones, and that OPN mRNA is expressed in the renal distal tubular cells. In the present study, we examined the immunohistochemical distributions of OPN and CPT in urinary stones. The stones used in this study were passed spontaneously from the upper urinary tract. One half of each of the stones was analyzed with an infrared spectrophotometer, and were shown to be comprised of calcium oxalate, calcium phosphate, uric acid and cystine. The other half of each stone was immersed in tetrasodium ethylenediamine-tetraacetate (EDTA) solution. The half-stones were embedded in paraffin and cut into 5-microm sections. The avidin-biotin-peroxidase complex technique was employed. A monoclonal antibody to human milk-derived OPN and a monoclonal antibody to human granulocyte-derived CPT were used as primary antibodies. The immunochemical study using the OPN and CPT antibodies showed positive staining of the matrix of the urinary calcium stones. The stones showed staining in two distinct zones: a core area was stained with randomly aggregated OPN and CPT, and peripheral layers were stained in concentric circles. On the basis of our observations, it is reasonable to presume that OPN and CPT play roles as the matrix in the structure of urinary calcium stones.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10460892     DOI: 10.1007/s002400050116

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  6 in total

1.  The mechanism of renal stone formation and renal failure induced by administration of melamine and cyanuric acid.

Authors:  Takahiro Kobayashi; Atsushi Okada; Yasuhiro Fujii; Kazuhiro Niimi; Shuzo Hamamoto; Takahiro Yasui; Keiichi Tozawa; Kenjiro Kohri
Journal:  Urol Res       Date:  2010-02-24

2.  Analysis of urinary calculi obtained from a patient with idiopathic hypouricemia using micro area x-ray diffractometry and LC-MS.

Authors:  Kiyoko Kaneko; Tomoyo Yamanobe; Maki Onoda; Ken-ichi Mawatari; Kazuya Nakagomi; Shin Fujimori
Journal:  Urol Res       Date:  2005-08-25

3.  Face-specific incorporation of osteopontin into urinary and inorganic calcium oxalate monohydrate and dihydrate crystals.

Authors:  Lauren A Thurgood; Alison F Cook; Esben S Sørensen; Rosemary L Ryall
Journal:  Urol Res       Date:  2010-07-22

4.  Mass spectroscopic characteristics of low molecular weight proteins extracted from calcium oxalate stones: preliminary study.

Authors:  Wen-Chi Chen; Chien-Chen Lai; Chein-Cheng Lai; Yuhsin Tsai; Yu-Hsin Tsai; Wei-Yong Lin; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

Review 5.  Biomolecular mechanism of urinary stone formation involving osteopontin.

Authors:  Kenjiro Kohri; Takahiro Yasui; Atsushi Okada; Masahito Hirose; Shuzo Hamamoto; Yasuhiro Fujii; Kazuhiro Niimi; Kazumi Taguchi
Journal:  Urol Res       Date:  2012-11-06

6.  Modulation of calcium oxalate dihydrate growth by selective crystal-face binding of phosphorylated osteopontin and polyaspartate peptide showing occlusion by sectoral (compositional) zoning.

Authors:  Yung-Ching Chien; David L Masica; Jeffrey J Gray; Sarah Nguyen; Hojatollah Vali; Marc D McKee
Journal:  J Biol Chem       Date:  2009-07-06       Impact factor: 5.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.